Related Experiment Video

Updated: May 30, 2026

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

Bioreduction-mediated food-drug interactions: opportunities for oncology nutrition

Melanie M Erzinger1, Shana J Sturla

  • 1ETH Zürich, Institute of Food, Nutrition and Health, Schmelzbergstrasse 9, CH-8092 Zürich.

Chimia
|July 30, 2011
PubMed

Insights

Bioactive food components (BFCs) can enhance cancer chemotherapy by modulating drug-metabolizing enzymes. Understanding these food-drug interactions can improve cancer treatment efficacy and patient nutrition.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Nutritional Science

Background:

  • Food-drug interactions (FDIs) in cancer therapy are complex and underexplored.
  • Metabolic activation of bioreductive anticancer drugs involves reductase enzymes.
  • Transcription factors regulate enzyme activity, influenced by bioactive food components (BFCs).

Purpose of the Study:

  • To systematically address the chemical and biochemical processes of FDIs in cancer therapy.
  • To explore the potential of BFCs in enhancing chemotherapy efficacy.
  • To inform nutritional recommendations and develop functional foods for cancer patients.

Main Methods:

  • Review of biochemical pathways of drug metabolism.
  • Analysis of molecular interactions between BFCs and metabolic enzymes.
  • Investigation of transcriptional regulation of xenobiotic metabolizing enzymes.

Main Results:

  • BFCs can modulate reductase enzyme activity, affecting drug metabolism.
  • Upregulation of xenobiotic metabolism and redox regulation enzymes by BFCs is a key mechanism.
  • BFCs show potential to overcome drug resistance and enhance synergistic drug effects.

Conclusions:

  • Understanding FDIs is crucial for optimizing cancer chemotherapy.
  • BFCs can be leveraged to improve treatment outcomes and patient care.
  • Further research can lead to novel functional foods for anticancer therapy.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...